Non-Invasive Neurostimulation in AD/ADRD (R01 Clinical Trial Optional)
Department of Health and Human Services National Institutes of Health
Posted on:
Fecha de Cierre:
Expired
Tipo
Research/project funding
Reference Number
PAR-19-298
The goal of this Funding Opportunity Announcement (FOA) is to encourage applications for studies using non-invasive neurostimulation/neuromodulation in the treatment of Alzheimer's Disease (AD) or Alzheimer's disease-related dementias (ADRD). The goal of this FOA is to establish initial efficacy of neurostimulation/neuromodulation in the treatment of AD/ADRD or to refine these interventions for AD/ADRD patients. Multimodal or combination interventions are allowed, provided the focus and innovative component is neurostimulation.
Categories: Health.
Categories: Health.
Estados Unidos